Mysoline
Utilised to manage cerebral seizure discharges to alleviate muscular convulsions and support motor baseline stability.
Mysoline details
- Conditions
- Seizure Disorders · Grand Mal Seizures
- Alternative names
- primidone
- Therapeutic class
- Barbiturate Anticonvulsant
- Pharmacological class
- Antiepileptic Agent
- Known off-label uses
- essential tremor
- Contraindications
- porphyria; hypersensitivity to phenobarbital
- Minor side effects
- drowsiness; dizziness; nausea
- Moderate side effects
- ataxia; nystagmus; irritability
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Originator
- Valeant Pharmaceuticals
- Onset Time
- 2–4 days
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Warfarin; Oral Contraceptives; Phenytoin
- Age restrictions
- Approved for paediatric and adult populations.
Serious side effects
suicidal ideation, requires immediate medical attention; severe blood dyscrasias, requires immediate medical attention
Patient summary
utilised to manage cerebral seizure discharges to alleviate muscular convulsions and support motor baseline stability.
Mechanism of action
Metabolises into phenobarbital, maximising GABA-mediated synaptic inhibition to raise the seizure threshold.
Pregnancy and breastfeeding
TGA Category D: High risk of congenital malformations and neonatal haemorrhage. Breastfeeding: Avoid.
What you will receive
Mysoline is the originator brand name, made by Valeant Pharmaceuticals. We use it to identify the medicine and are not affiliated with Valeant Pharmaceuticals.
- The fulfilment partner confirms whether the exact brand or an equivalent containing Primidone is offered.
- The offered brand, manufacturer and dispatch location depend on the product, destination and partner warehouse.
- Check the final product details at checkout before confirming an order.